Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial-Reference-Cited by-同舟云学术

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

Published:2016-11 Issue:3 Volume:1 Page:185-195
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Chan Henry L Y,Fung Scott,Seto Wai Kay,Chuang Wan-Long,Chen Chi-Yi,Kim Hyung Joon,Hui Aric Josun,Janssen Harry L A,Chowdhury Abhijit,Tsang Tak Yin Owen,Mehta Rajiv,Gane Edward,Flaherty John F,Massetto Benedetta,Gaggar Anuj,Kitrinos Kathryn M,Lin Lanjia,Subramanian G Mani,McHutchison John G,Lim Young-Suk,Acharya Subrat K,Agarwal Kosh

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference39 articles.

1. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013;Schweitzer;Lancet,2015

2. Chronic hepatitis B infection;Kuo;Clin Liver Dis,2012

3. Chronic hepatitis B virus infection;McMahon;Med Clin North Am,2014

4. Chronic hepatitis B: virology, natural history, current management and a glimpse at future opportunities;Gish;Antivir Res,2015

5. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010;Lozano;Lancet,2012

Cited by 370 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term hepatitis B surface antigen response after finite treatment of ARC-520 or JNJ-3989;Gut;2024-09-12

2. Hepatitis B Management in the Middle East: A Narrative Review of Current Antiviral Treatments;Gastrointestinal Disorders;2024-09-12

3. Comparative efficacy and safety of tenofovir amibufenamide vs tenofovir alafenamide in the initial 48-week treatment of high viral load chronic hepatitis B: A single-centre retrospective study;Antiviral Therapy;2024-09-11

4. Simplified Chronic Hepatitis B Antiviral Initiation Criteria in Thailand: An Economic Evaluation;Value in Health Regional Issues;2024-09

5. Functional cure induced by tenofovir alafenamide plus peginterferon-alpha-2b in young children with chronic hepatitis B: a case series study;BMC Infectious Diseases;2024-08-15